EC detains 11.5M life sciences products for IP violations; Sanofi is working on fixes to French vax plant;

> The European Commission Customs Union seized 11.5 million medicines and medical products for suspected violations of intellectual property in 2009. Article

> Sanofi Pasteur CEO Wayne Pisano has responded to a July letter from the FDA by saying the vaccine maker has already addressed, or is currently addressing, microbial contamination and other manufacturing shortcomings at a plant in France. Article

> Specialty pharma Global Health Ventures has signed an agreement with Canadian CMO Carter Pharmaceutical to manufacture 10,000 pills of the sublingual formulation for anti-anxiety drug Relax-B for testing. Release

> Green Planet Bioengineering has received a patent for the "sync effective" extraction process it uses in making Salvia Miltiorrhiza for use in health supplements and prescription drugs. Release

> Romanian pharma distributor Relad has begun dynamic routing after adopting ORTEC's Transport and Distribution solution. Release


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.